AUScelerate
Independent not-for-profit life‑sciences accelerator (est. 2015) that delivers grant-funded translation and commercialisation programs, intermediary services and capacity-building for medtech, biotech, diagnostics and digital health innovators. Operates accelerator cohorts and funding rounds, manages networks and consortia, runs international trade missions and site‑visit programs, and provides commercialisation, regulatory, manufacturing and project support to advance early-stage technologies toward clinical evaluation and market entry.
Industries
Nr. of Employees
small (1-50)
AUScelerate
Dendy, Were Street Po, Brighton, Brighton North, Victoria, Australia
Services
Designs and runs funded accelerator cohorts and competitive funding rounds to progress early‑stage life sciences projects toward clinical proof‑of‑concept and commercial readiness.
Manages application processes, award allocations and reporting for government‑backed translation and commercialisation grants.
Provides strategic commercial advice, investor‑readiness coaching and curated capital engagement to prepare companies for investment and partnerships.
Acts as an intermediary between innovators, industry partners, government and infrastructure providers to broker strategic connections and partnerships.
Provides capability assessment, tailored workshops and procurement masterclasses to position medtech SMEs for local health procurement and buyer engagement.
Manages a state‑level innovation hub to connect local research, industry and government, deliver events and provide connection to national and international networks.
Designs and runs funded accelerator cohorts and competitive funding rounds to progress early‑stage life sciences projects toward clinical proof‑of‑concept and commercial readiness.
Manages application processes, award allocations and reporting for government‑backed translation and commercialisation grants.
Provides strategic commercial advice, investor‑readiness coaching and curated capital engagement to prepare companies for investment and partnerships.
Acts as an intermediary between innovators, industry partners, government and infrastructure providers to broker strategic connections and partnerships.
Provides capability assessment, tailored workshops and procurement masterclasses to position medtech SMEs for local health procurement and buyer engagement.
Manages a state‑level innovation hub to connect local research, industry and government, deliver events and provide connection to national and international networks.
Expertise Areas
- Medical device translation and commercialisation
- Clinical trial enablement for early‑phase studies
- Accelerator program design and delivery
- Grant and funding program administration
Key Technologies
- Point‑of‑care lateral flow diagnostics
- Wearable biosensors
- Automated GLP/GMP biomanufacturing
- 3D printing for medical device components
News & Updates
Curated pre‑conference site visits and investor pitch sessions to support US market engagement for medtech companies.
Two‑track delegation offering ecosystem immersion and executive partnering to support Australian organisations exploring China market opportunities.
State‑level medtech showcase and capability uplift activities to connect local manufacturers with health service procurement and buyers.
Impact summary of the Biomedical Translation Bridge program including technology progression, product launches and sector investment figures.
Summary of a curated capital engagement program including investor education and showcase activities to connect companies with private capital networks.
Program reported multiple technology progressions and sector outcomes including new technologies advanced, products launched, jobs created and external investment attracted.
Curated pre‑conference site visits and investor pitch sessions to support US market engagement for medtech companies.
Two‑track delegation offering ecosystem immersion and executive partnering to support Australian organisations exploring China market opportunities.
State‑level medtech showcase and capability uplift activities to connect local manufacturers with health service procurement and buyers.
Impact summary of the Biomedical Translation Bridge program including technology progression, product launches and sector investment figures.
Summary of a curated capital engagement program including investor education and showcase activities to connect companies with private capital networks.
Program reported multiple technology progressions and sector outcomes including new technologies advanced, products launched, jobs created and external investment attracted.